Taking an ethical and responsible approach in the best interest of our patients informs everything we do. From business development activities, to transparency around funding decisions, our approach prioritises serving patients and creating enduring value for our stakeholders.
We are committed to leading the way in adopting and applying the highest standards of good governance, ethics and transparency in our industry and have signed up to the ABPI and EFPIA transparency initiative – Disclosure UK. Disclosure UK is part of a Europe-wide initiative to increase transparency between pharmaceutical companies and the doctors, nurses, pharmacists and other health professionals and organisations it works with.
Shire’s goal is to reinforce the authentic relationship between pharmaceutical companies and healthcare professionals, by supporting the principles of transparency and disclosing our annual payments as directed by the EFPIA and local disclosure codes. To view our EFPIA reports please click here.
Patient Groups – or patient advocacy groups and patient organisations – are important partners for Shire. Our aim is to forge trusting, mutually-beneficial relationships with patient groups. To build and maintain this trust, we are committed to understanding and addressing unmet needs in the patient community.
We support patient organisations in our therapeutic areas through sponsorships, grants and donations.
Shire provides funding in the form of unrestricted educational grants to support independent medical education activities for healthcare professionals.
Shire makes charitable donations (to include both cash and in-kind giving) to local, national and international organisations that support Shire’s communities and/or diseases in its therapeutic focus area.
If you would like to request a donation for a UK registered charity, please email email@example.com.